| 2020 | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
| CANCER RESEARCH AND TREATMENT |
| 2020 | Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia
| CANCER MEDICINE |
| 2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
| 2020 | Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners | PATIENT EDUCATION AND COUNSELING |
| 2020 | Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL) | BONE MARROW TRANSPLANTATION |
| 2020 | Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
| SCIENTIFIC REPORTS |
| 2020 | Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study | INTERNATIONAL JOURNAL OF HEMATOLOGY |
| 2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
| 2020 | ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
| CANCER RESEARCH AND TREATMENT |
| 2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria | BLOOD |
| 2019 | Clinical Implication of Renal Dysfunction During the Clinical Course in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Longitudinal Analysis | ANNALS OF HEMATOLOGY |
| 2019 | 후천성 혈우병 A
| Clinical and Experimental Thrombosis and Hemostasis |
| 2019 | 국소적 대상포진이 발생한 면역저하환자로부터 유발된 수두의 발생
| Korean Journal of Nosocomial Infection Control (병원감염관리) |
| 2019 | Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/-DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2019 | Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2019 | A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2019 | Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization | Japanese Journal of Clinical Oncology |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
| 2018 | A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System | BRITISH JOURNAL OF HAEMATOLOGY |
| 2017 | Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy | AMERICAN JOURNAL OF HEMATOLOGY |
| 2017 | Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. | LANCET HAEMATOLOGY |
| 2017 | Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study. | LEUKEMIA |
| 2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
| ONCOTARGET |
| 2017 | Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
| ONCOTARGET |
| 2017 | Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma | HEMATOLOGICAL ONCOLOGY |
| 2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| ONCOTARGET |
| 2017 | The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)
| ONCOTARGET |
| 2017 | Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
| BLOOD RESEARCH |
| 2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
| 2017 | Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort
| BLOOD RESEARCH |
| 2017 | Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
| BLOOD RESEARCH |
| 2017 | Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2017 | Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
| RADIATION ONCOLOGY JOURNAL |
| 2017 | Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores | ANNALS OF HEMATOLOGY |
| 2017 | Hematopoietic stem cell mobilization: current status and future perspective
| BLOOD RESEARCH |
| 2017 | 내과 전문의 시험제도의 발전방향
| Korean Journal of Medicine |
| 2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
| 2017 | Prognostic significance of interventricular septal thickness in patients with AL amyloidosis | LEUKEMIA RESEARCH |
| 2017 | AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells | CLINICAL CANCER RESEARCH |
| 2017 | Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
| YONSEI MEDICAL JOURNAL |
| 2017 | Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells. | AUTOPHAGY |
| 2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | ANNALS OF HEMATOLOGY |
| 2016 | Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
| BMC CANCER |
| 2016 | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | LANCET ONCOLOGY |
| 2016 | Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia | ANNALS OF ONCOLOGY |
| 2016 | Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
| BLOOD RESEARCH |
| 2016 | A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas | ANNALS OF ONCOLOGY |
http://orcid.org/0000-0001-8986-8436
(55032033600)
